Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for adjuvant colon cancer, metastatic colorectal cancer, and metastatic breast cancer.
Learn about EMPLICITI™ (elotuzumab) treatment which includes information about ongoing support and resources.
Learn about COMETRIQ®, a treatment for medullary thyroid cancer (MTC) that has spread to other parts of the body, and read the Important Safety Information.
Discover FEMARA® (letrozole), an approved treatment from Novartis Oncology for HR+ breast cancer in postmenopausal women. Learn about FEMARA® side ...
Buy Mouthwash BLM and Simethicone Compounding Kit at Cutis Pharma.
LIBTAYO (cemiplimab-rwlc) is an FDA-approved therapy for patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. Serious side effects may occur. Please see Important Safety Information and full Prescribing Information on site. Information on these pages is intended for US HCPs only. LIBTAYO, Ce...
Find information about Herceptin® (trastuzumab), a targeted therapy for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
LONSURF is a prescription oral medicine indicated for patients with refractory metastatic colorectal cancer (mCRC) who have previously used other treatment options. Please see Important Safety Information and full Prescribing Information.
Juno is a clinical-stage cell immunotherapy company focused on revolutionizing medicine by re-engaging the body’s immune system to treat cancer4
LORBRENA is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on
FoundationOne CDx is the first FDA-approved broad companion diagnostic (CDx) that is clinically and analytically validated for solid tumors
Learn more about LUMOXITI (moxetumomab pasudotox) approved for treatment of refractory HCL. LUMOXITI is for your adult patients with HCL that received two prior treatments including a PNA.
Mouthwash-GP™ is a mouthwash base designed to simplify and standardize the extemporaneous compounding of formulations for delivery to the oral cavity. The pH of Mouthwash-GP™ is buffered to match the natural pH of saliva.
Find information about approved indications for KEYTRUDA® (pembrolizumab), along with treatment guidelines for health care professionals.
There are several key components to our CAR technology, each of which may have a significant impact on its utility in cancer immunotherapy.
Click here to learn more about NINLARO® (ixazomib).
See risks and benefits. Nivestym™ (filgrastim-aafi) is a biosimilar of NEUPOGEN® (filgrastim). Read more about the indications and info on biosimilars. Keywords: acute myeloid leukemia, neutropenia, idopathic neutropenia, leukemias
Siemens mammography systems mark a new era in breast care imaging offering uncompromised image quality, up to 30% lower dose, greater patient comfort,
The Global Leader in Breast Biopsy Markers